SS
ORIC icon

Steve Schonfeld’s Oric Pharmaceuticals ORIC Stock Holding History

Steve Schonfeld’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,349
Closed -$117K – 2548
2025
Q4 		$117K Buy
+14,349
New +$165K ﹤0.01% 1795
2025
Q2 		– Sell
-426,902
Closed -$2.38M – 2406
2025
Q1 		$2.38M Sell
426,902
-297,417
-41% -$2.6M 0.01% 876
2024
Q4 		$5.85M Buy
+724,319
New +$6.65M 0.03% 454
2022
Q4 		– Sell
-11,800
Closed -$38K – 2894
2022
Q3 		$38K Sell
11,800
-18,000
-60% -$72.1K ﹤0.01% 2669
2022
Q2 		$133K Buy
29,800
+2,200
+8% +$8.78K ﹤0.01% 2060
2022
Q1 		$148K Buy
+27,600
New +$249K ﹤0.01% 2105

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Steve Schonfeld's ORIC Position: Q1 2026 in Review

Steve Schonfeld sold out of Oric Pharmaceuticals (ORIC) in Q1 2026, closing a stake of 14,349 shares — an estimated $117K sold.

Steve Schonfeld first reported a position in ORIC in Q1 2022 and held it in 6 quarters. The position peaked at $5.85M in Q4 2024. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Steve Schonfeld reported no remaining Oric Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Steve Schonfeld sold 14,349 Oric Pharmaceuticals shares in Q1 2026, an estimated $117K.
  • Steve Schonfeld first reported a position in Oric Pharmaceuticals in Q1 2022 and held it in 6 quarters.
  • Steve Schonfeld's Oric Pharmaceuticals position peaked at $5.85M in Q4 2024.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.